IIBA UK CHAPTER

Company Registration Number:
06067668 (England and Wales)

Unaudited micro entity accounts for the year ended 31 January 2024

Period of accounts

Start date: 01 February 2023

End date: 31 January 2024

IIBA UK CHAPTER

Contents of the Financial Statements

for the Period Ended 31 January 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

IIBA UK CHAPTER

Company Information

for the Period Ended 31 January 2024




Director: Elizabeth May Calder
Bindu Channaveerappa
James Lee Compton
Alison Margaret Fairclough
Kamal Singh Marwaha
Samuel Kanin Merrick
Gavin Scott Ross
Christina Tan
Jason Michael Thompson
Andrew Peter Turner
Julia Mary Newell
Stuart Alan Mullinger
Secretary: Christina Tan
Registered office: 20-22
Wenlock Road
London
N1 7GU
Company Registration Number: 06067668 (England and Wales)

IIBA UK CHAPTER

Directors' Report Period Ended 31 January 2024

The directors present their report with the financial statements of the company for the period ended 31 January 2024

Principal Activities

IIBA UK promotes the Business Analysis profession within the UK. Its principal activities include the offering of professional networking and knowledge-share events, mentoring schemes and study groups.

Political and charitable donations

IIBA UK is not affiliated with any political parties or charities.

Company policy on the employment of disabled persons

Company policy on disabled employees is not applicable as IIBA UK is operated entirely by volunteers.

Directors

The directors shown below have held office during the whole of the period from 01 February 2023 to 31 January 2024
Elizabeth May Calder
Bindu Channaveerappa
James Lee Compton
Samuel Kanin Merrick
Gavin Scott Ross
Christina Tan
Andrew Peter Turner

The director(s) shown below were appointed to the company during the period
Alison Margaret Fairclough
01 July 2023
Kamal Singh Marwaha
03 January 2024
Jason Michael Thompson
30 March 2023

The director(s) shown below resigned during the period
Julia Mary Newell
09 May 2023
Stuart Alan Mullinger
03 January 2024

Secretary
Christina Tan

This report was approved by the board of directors on 19 February 2024
And Signed On Behalf Of The Board By:

Name: Elizabeth May Calder
Status: Director

IIBA UK CHAPTER

Profit and Loss Account

for the Period Ended 31 January 2024


2024
£

2023
£
Turnover 26,876 14,618
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 446 ) ( 286 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 13,089 ) ( 16,644 )
Tax on Profit ( 3,335 ) ( 0 )
Profit or (Loss) for Period 10,006 ( 2,312 )

IIBA UK CHAPTER

Balance sheet

As at 31 January 2024


2024
£

2023
£
Current assets: 230,415 217,074
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 230,415 217,074
Total assets less current liabilities: 230,415 217,074
Total net assets (liabilities): 230,415 217,074
Capital and reserves: 230,415 217,074

IIBA UK CHAPTER

Balance sheet continued

For the year ending 31 January 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 19 February 2024
And Signed On Behalf Of The Board By:

Name: Elizabeth May Calder
Status: Director

The notes form part of these financial statements

IIBA UK CHAPTER

Footnotes to the Financial Statements

for the Period Ended 31 January 2024

  • 1. Employee Information

    Average number of employees: 0

IIBA UK CHAPTER

Footnotes to the Financial Statements

for the Period Ended 31 January 2024

  • 2. Off balance sheet disclosure

    No